This partnership encompasses dossier licensing, bulk product supply, and the licensing of ZIM Labs’ proprietary Oral Thin Film technology platform, ThinOral
Approval brings AstraZeneca and Daiichi Sankyo’s Enhertu earlier in the treatment of HR-positive, HER2-low breast cancer and broadens the eligible patient population to those with HER2-ultralow disease
The company offers customized formulations tailored to align with each brand’s identity and consumer needs
PRX-PLUS has a unique product feature with its deep-impacting formula
Lonza’s new simplified and streamlined operating model is designed to support its One Lonza vision and strategy
The consignment of USFDA qualified Metformin (1000mg) was received by the province of Mendoza for distribution in the public health system
The new combination therapy offers a dual mechanism of action for superior intraocular pressure control
Omega 3 oil 18 EPA/12 DHA is highly demanded worldwide for its multiple benefits for human and animal health
The freshly infused capital will primarily be deployed towards expansion and research & development
Abbott's investigational Coronary Intravascular Lithotripsy (IVL) System offers a new potential treatment by using sound pressure waves to treat arterial calcium blockages
Subscribe To Our Newsletter & Stay Updated
